Raymark Corporation / Raytech Corporation Asbestos Trust Fund Claims

Raymark and Raytech Trust Facts

Why Raymark Claims Use the Raytech Trust

The Trust’s governing TDP does not establish one asbestos trust for Raymark and another separate asbestos trust for Raytech. Instead, it defines covered PI Trust Claims as personal-injury and death claims caused by exposure to asbestos-containing products for which Raymark Industries, Inc. and its predecessors and affiliates have legal liability that could be asserted against Raytech Corporation.

The official Raytech claim form reinforces this structure. It asks whether the injured person previously received payment for asbestos injury involving products manufactured, produced, distributed, sold, fabricated, installed, released, maintained, repaired, replaced, removed or handled by Raytech or an entity for which Raytech is responsible, expressly including Raymark Industries, Inc., Raymark Corporation and Universal Friction Composites, Inc.

For that reason, this page preserves the Raymark/Raytech reader intent while identifying the correct formal trust rather than inventing a second funding pool.

Raymark, Raybestos and Raytech History

The liabilities behind the Trust are tied to the historic friction-products businesses associated with Raybestos-Manhattan and later Raymark. These businesses manufactured asbestos-containing brake and clutch friction products used in automotive and industrial applications.

Raytech Corporation later became the debtor in the reorganization that resulted in the current Trust structure. The Raytech and Raymark reorganization plans, together with the Trust Agreement, establish the Raytech Corporation Asbestos Personal Injury Settlement Trust.

The corporate history matters for exposure analysis because a claimant may remember a Raybestos or Raymark brake or clutch product rather than the Raytech corporate name. The governing Trust documents determine whether that exposure falls within the covered liability.

Current Adjusted Disease Values

The Trustees issued an official adjustment dated July 31, 2024 increasing the liquidated values in Schedule B to account for CPI changes. The notice states that the adjusted values apply to outstanding and future offers:

These are liquidated claim values used under the Trust procedures. They are not guaranteed cash payments. The current Pro-rata Percentage is applied to the applicable liquidated value.

Need help now? Call 800.291.0963
Live chat available 24/7, 365 days a year.
Submit Your Case

Current 1.35% Pro-rata Percentage

An official Trustee notice dated November 19, 2024 states that the Trustees increased the Trust’s Pro-rata Percentage from 0.92% to 1.35%, effective November 14, 2024.

The percentage is periodically reconsidered using current estimates of the number, types and values of present and future claims, available Trust assets, liquidity, administrative expenses and other material factors affecting the Trust’s ability to treat present and future claimants comparably.

Mathematical illustration only — not a guaranteed payment. $179,760 current adjusted Mesothelioma value × 1.35% = approximately $2,426.76. $59,249 current adjusted Lung Cancer value × 1.35% = approximately $799.86. Eligibility, claim classification, releases and all other Trust requirements still apply.

Medical and Exposure Requirements

For Malignant Mesothelioma Category I, the TDP requires a qualifying diagnosis and meaningful and credible exposure to Raytech Product/Operations before December 31, 1982, together with evidence establishing the required 10-year latency period between first asbestos exposure and diagnosis.

Lung Cancer Category II requires a primary lung-cancer diagnosis, evidence supporting asbestos exposure as a contributing factor, underlying asbestos-related disease, qualifying pre-December 31, 1982 exposure and the TDP’s latency criteria.

Other Cancer and Severely Disabling Asbestosis have their own medical and exposure requirements. The fact that a person worked around automotive brakes, clutches or friction materials does not by itself prove exposure to a product or operation covered by this Trust.

Claim Filing and $75 Processing Fee

Claims are processed through Claims Processing Facility, Inc. using Raytech-specific filing instructions and proof-of-claim materials.

The Trustees announced that, for claims submitted on or after June 1, 2023, a $75 claim processing fee must be paid before the Trust will process the claim. If the fee is not received within 60 days of the Trust’s receipt of the claim, the claim may be rejected and the statute of limitations will not be treated as tolled under the fee notice.

The $75 fee is refunded in full if the claim is approved for payment. It may be forfeited if a denied claim is not cured within the allowed period, if the claimant withdraws the claim or if the Trust withdraws it under applicable procedures.

CPF maintains current Raytech filing instructions, claim forms, approved job-site resources, presumptive occupations, physician information, deficiency codes and other Trust-specific materials.

Special Claim Procedures

The Raytech TDP addresses Extraordinary Claims, Exigent Health Claims, Extreme Hardship Claims, Indirect Claims, releases and alternative dispute resolution.

Special treatment is not automatic. A claimant must satisfy the specific standards in the governing procedures for the requested treatment.

The current official CPF page confirms the Trust remains active and continues processing asbestos claims. A sufficiently current 2025 or 2026 audited financial statement was not independently extracted during this build, so current total assets, current annual claim payments and cumulative lifetime dollars paid are omitted rather than inferred from older financial reports.

Confirmed Primary Sources for Trust Facts

No law-firm or lead-generation website was used as factual authority for this page. Primary materials reviewed include:

• Official Claims Processing Facility Raytech Trust page.
• Official Raytech Third Amended and Restated Asbestos Personal Injury Settlement Trust Distribution Procedures.
• Official November 19, 2024 Pro-rata Percentage increase notice.
• Official July 31, 2024 adjusted liquidated-value notice.
• Official Raytech claim filing instructions.
• Official Raytech asbestos personal-injury claim form identifying Raymark Industries and Raymark Corporation.
• Official May 1, 2023 claim-processing-fee notice.

Get Help Reviewing a Raymark / Raytech Asbestos Claim

Call 800.291.0963

Live chat is available 24/7, 365 days a year.

Submit Your Case

Exposure to a Raybestos, Raymark or related friction product does not automatically establish Trust eligibility or compensation. Eligibility depends on diagnosis, qualifying covered exposure, medical documentation, current Trust procedures, filing requirements and individual circumstances. Compensation is not guaranteed.